Benefits
Sarcopenia in elderly 24-week RCT (Susan/Gillian/Bonnet/Donovan 2021)
JOJ Case Stud 12(5):555850 randomized double-blind placebo-controlled study trial. Elderly adults with sarcopenia. Naticol® fish collagen peptides 15 g/day for 24 weeks vs placebo. Lancaster Hall, Cork research site. RESULTS: SIGNIFICANTLY IMPROVED SARCOPENIA SYMPTOMS by INCREASING LEAN MUSCLE MASS + INCREASING MUSCULAR FUNCTION via handgrip strength assessment + Short Physical Performance Battery + Chair Stand Test. Foundational sarcopenia-prevention evidence. Important indication for older adult muscle preservation.
Skin aging 12-week LOW-DOSE RCT (Naticol-Cyskin)
JOJ Case Stud — 12-week double-blind placebo-controlled RCT in 57 mature women. 2.5 g Naticol or Naticol+silicon (Cyskin) or maltodextrin placebo daily. Cutometer SEM (skin elasticity), Corneometer CM 825 (hydration), Dermascan C (skin thickness), Chromameter CR 400 (color), Bazin-Doublet's atlas (wrinkles), VAS (radiance/complexion homogeneity). RESULTS: Both Naticol groups REDUCED visible signs of aging. LOW DOSE 2.5 g/day effectiveness — important for product formulators (lower dose = more practical product format). Distinguishes from competing collagen products requiring 5-10 g.
NATICOL weight management 3-month RCT (NCT03872297)
NCT03872297 NATICOL trial COMPLETED — Institut Pasteur de Lille (France) sponsored. Quadruple-masked (participants, care providers, investigators, outcomes assessors) parallel randomized trial. Healthy overweight volunteers. 3-month Naticol fish collagen peptide supplementation vs placebo. Body composition via DXA + 2 blood tests + 2 stool collections. Pilot study following animal data showing fish collagen peptides limit weight gain + fat mass increase in mice. Recent novel weight management evidence.
Joint health and osteoarthritis (clinical evidence)
Manufacturer-cited clinical studies have suggested Naticol® has BENEFICIAL EFFECTS on JOINT HEALTH such as OSTEOARTHRITIS. Joint comfort + supports physical performance. Mechanism: type I collagen peptides + amino acid building blocks for cartilage matrix. Less robust than skin or sarcopenia evidence but consistent broader collagen literature support.
Sustainable circular economy upcycling
Distinguishing feature: Naticol® is produced from FISH SKINS UPCYCLED from fish filleting industry by-products that would otherwise be discarded. Sustainable circular economy model. Sustainable species sourced. Important environmental positioning relevant to modern consumer values.
Premium organoleptic profile (formulation advantage)
Naticol® organoleptic features: NEUTRAL ODOR + NEUTRAL TASTE + COLORLESS + WATER-SOLUBLE + HEAT-RESISTANT — distinguishes from competing collagen products. Important formulation advantages for functional beverages, hot drinks, sachets, capsules. Naticol® instant powder rapidly dissolves in drinks/smoothies. Practical advantages for product developers + end users.
High protein purity (>99% on dry matter)
>99% PROTEIN CONTENT ON DRY MATTER — among the purest collagen peptides on market. Specific amino-acid profile + unique molecular weight distribution from Weishardt's proprietary process. Mechanism: high purity supports consistent clinical efficacy + product quality.
Mechanism of action
Type I collagen peptide bioavailability
Type I collagen accounts for >75% of protein in connective tissues and skin. Naticol® specific small peptides via enzymatic hydrolysis are HIGHLY BIOAVAILABLE — rapidly absorbed by the body. Mechanism for measurable clinical effects vs poorly absorbed bulk collagen products.
Amino acid pool for collagen synthesis
Provides amino acid building blocks (especially glycine, proline, hydroxyproline) for endogenous collagen synthesis in skin, bone, cartilage, muscle. Mechanism for multi-tissue benefits.
Specific peptide bioactivity
Beyond pure amino acid provision, specific small peptides (di- and tripeptides) retain bioactivity to stimulate fibroblasts, chondrocytes, and other cells synthesizing extracellular matrix. Distinguishes from generic collagen sources.
MMP inhibition (matrix metalloproteinase)
Inhibits MMPs that degrade collagen — protects existing matrix from breakdown. Combined with stimulating new matrix synthesis, provides dual protective + restorative mechanism.
Muscle protein synthesis stimulation
Sarcopenia trial mechanism: collagen peptides + leucine-containing fragments stimulate muscle protein synthesis. Mechanism for elderly muscle mass preservation.
Marine collagen distinction from bovine/porcine
Marine type I collagen has slightly different amino acid profile and molecular characteristics vs bovine/porcine collagen. Some research suggests marine collagen has enhanced bioavailability + lower allergy risk for those avoiding mammalian collagen.
Clinical trials
Randomized double-blind placebo-controlled study trial (Susan MT, Gillian DG, Christelle BB, Ted GD 2021, JOJ Case Stud 12(5):555850).
Elderly adults with sarcopenia symptoms. Naticol® fish collagen peptides 15 g/day in single-dose sachets vs placebo for 24 weeks. Lancaster Hall, 6 Little Hanover Street, Cork. Helsinki Declaration consent.
SIGNIFICANTLY IMPROVED SARCOPENIA SYMPTOMS vs placebo. INCREASED LEAN MUSCLE MASS + INCREASED MUSCULAR FUNCTION via: handgrip strength assessment, Short Physical Performance Battery, Chair Stand Test. Foundational sarcopenia-prevention evidence in elderly. Important real-world functional outcomes (handgrip, mobility tests). Industry-related (Christelle Bruno-Bonnet, Weishardt International) — important context.
Double-blind placebo-controlled randomized study (JOJ Case Studies).
57 mature women. Three arms: 2.5 g Naticol/day, 2.5 g Naticol + silicon (Naticol-Cyskin)/day, or maltodextrin placebo. 12 weeks. Cutometer SEM elasticity, Corneometer CM 825 hydration, Dermascan C thickness, Chromameter CR 400 color, Bazin-Doublet's atlas wrinkles, VAS radiance/complexion homogeneity assessments at baseline, week 8, week 12.
Both Naticol groups REDUCED VISIBLE SIGNS OF AGING (wrinkles, fine lines, dry skin) at LOW DOSE 2.5 g/day. Important demonstration that Naticol's specific peptide profile achieves clinical effects at lower doses than typical collagen products (5-10 g). 2.5 g format now available for product formulation via AIDP US distribution. Industry-related context.
Randomized quadruple-masked parallel randomized clinical trial (NCT03872297, Institut Pasteur de Lille, France).
Healthy overweight volunteers. Naticol fish collagen peptide supplementation vs placebo for 3 months. DXA body composition + 2 blood tests + 2 stool collections at baseline and end of study. Pilot study following preclinical mouse data.
COMPLETED study (NCT03872297). Pilot study investigating fish collagen peptide effects on weight, body composition, and glycemic response in humans. Following mouse data showing fish collagen peptides limit weight gain + fat mass increase in obese mouse model. Novel weight management application evidence. Status: COMPLETED — results emerging.
About this ingredient
Naticol® is a BRANDED MARINE FISH COLLAGEN PEPTIDE manufactured by WEISHARDT INTERNATIONAL (France) — a 170+ year-old leader in collagen and gelatin industry. Type I marine collagen peptides via PROPRIETARY ENZYMATIC HYDROLYSIS of FISH SKINS. SUSTAINABLE CIRCULAR ECONOMY — Weishardt UPCYCLES fish skins discarded by fish fillet industry into premium value-added product. Sustainable species sourced. >99% PROTEIN CONTENT ON DRY MATTER — among purest collagen peptides on market. Specific amino acid profile + unique molecular weight distribution for high bioavailability + rapid absorption. NATICOL-CYSKIN combination with BCF Life Sciences offers enhanced skin beauty benefits via synergistic active ingredients. ORGANOLEPTIC ADVANTAGES: NEUTRAL ODOR + NEUTRAL TASTE + COLORLESS + WATER-SOLUBLE + HEAT-RESISTANT — distinguishing formulation features for functional beverages, hot drinks, sachets, capsules, soft gels. Two main forms: STANDARD POWDER + INSTANT POWDER (rapid dissolution for drinks/smoothies). CLINICAL EVIDENCE BASE: SARCOPENIA 24-WEEK RCT (Susan/Gillian/Bonnet/Donovan 2021, JOJ Case Stud 12(5):555850) at 15 g/day Naticol® demonstrated significantly improved sarcopenia symptoms with increased lean muscle mass + handgrip strength + Short Physical Performance Battery + Chair Stand Test improvements in elderly. SKIN AGING 12-WEEK LOW-DOSE RCT in 57 mature women at 2.5 g/day Naticol or Naticol-Cyskin reduced visible signs of aging (wrinkles, fine lines, dry skin) — demonstrating clinical efficacy at LOWER DOSE than typical collagen products. NCT03872297 NATICOL TRIAL Institut Pasteur de Lille 3-month quadruple-masked weight management trial in overweight volunteers (COMPLETED). Two skin beauty clinical studies + sport, joint health, weight management studies per Weishardt research base. Total of multiple clinical studies supporting various claims.
MECHANISMS: Type I collagen peptide bioavailability (highly absorbable small peptides); amino acid pool for collagen synthesis (glycine, proline, hydroxyproline); specific peptide bioactivity beyond pure amino acid provision (di/tripeptide fibroblast/chondrocyte stimulation); MMP inhibition matrix metalloproteinase suppression; muscle protein synthesis stimulation (sarcopenia trial mechanism); marine collagen distinction from bovine/porcine. EVIDENCE: 3/5 reflects: (1) NATICOL SARCOPENIA 24-WEEK PIVOTAL RCT in elderly with multi-functional outcomes (lean mass + handgrip + SPPB + Chair Stand), (2) NATICOL SKIN AGING 12-WEEK LOW-DOSE RCT (n=57 mature women) demonstrating efficacy at 2.5 g/day, (3) NCT03872297 NATICOL weight management 3-month pilot, (4) WELL-CHARACTERIZED type I collagen peptide bioavailability mechanism, (5) HIGH PURITY (>99% protein on dry matter) standardization, (6) MULTI-INDICATION evidence base (skin, sarcopenia, weight, joint), (7) SUSTAINABLE upcycled circular economy positioning, (8) NEUTRAL ORGANOLEPTIC profile distinguishing formulation advantage, (9) industry-related evidence (Weishardt International + AIDP US distribution) — important context. SAFETY: Excellent — food-grade marine origin with extensive use record. Best positioned as: (a) ELDERLY SARCOPENIA prevention adjunct (24-week RCT evidence with multi-functional outcomes — important indication for healthy aging), (b) SKIN AGING in mature women (low-dose 2.5 g/day effective vs typical 5-10 g products), (c) JOINT COMFORT general support, (d) WEIGHT MANAGEMENT adjunct (NCT03872297 emerging evidence), (e) SUSTAINABLE COLLAGEN alternative for environmentally-conscious consumers, (f) NEUTRAL ORGANOLEPTIC profile preferred for functional beverages and hot drinks, (g) MARINE ALTERNATIVE to bovine collagen for those avoiding mammalian sources, (h) FISH-ALLERGIC: AVOID, (i) DAILY long-term use acceptable based on safety profile. Honest framing: Naticol® has rigorous evidence base — sarcopenia 24-week RCT in elderly with multiple functional outcomes is methodologically robust, low-dose 2.5 g/day skin aging efficacy is genuinely useful for product formulation. Sustainable upcycling positioning is increasingly relevant to modern consumers. Industry-related context (Weishardt + AIDP) warrants caveat but methodology rigorous. Reasonable skin/muscle/joint adjunct based on evidence — particularly compelling alternative to bovine collagen for marine collagen preferences + low-dose convenience.